These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 21316416)

  • 1. Gene expression profile of ADAMs and ADAMTSs metalloproteinases in normal and malignant plasma cells and in the bone marrow environment.
    Bret C; Hose D; Reme T; Kassambara A; Seckinger A; Meissner T; Schved JF; Kanouni T; Goldschmidt H; Klein B
    Exp Hematol; 2011 May; 39(5):546-557.e8. PubMed ID: 21316416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging roles of ADAM and ADAMTS metalloproteinases in cancer.
    Rocks N; Paulissen G; El Hour M; Quesada F; Crahay C; Gueders M; Foidart JM; Noel A; Cataldo D
    Biochimie; 2008 Feb; 90(2):369-79. PubMed ID: 17920749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
    Martín P; Santón A; Bellas C
    Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the microenvironment and adhesion of cancer cells by ADAMs (a disintegrin and metalloproteinase).
    Okada Y
    Verh Dtsch Ges Pathol; 2007; 91():29-38. PubMed ID: 18314593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of ADAMs and their inhibitors in sputum from patients with asthma.
    Paulissen G; Rocks N; Quesada-Calvo F; Gosset P; Foidart JM; Noel A; Louis R; Cataldo DD
    Mol Med; 2006; 12(7-8):171-9. PubMed ID: 17088949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone morphogenetic proteins and receptors are over-expressed in bone-marrow cells of multiple myeloma patients and support myeloma cells by inducing ID genes.
    Grcević D; Kusec R; Kovacić N; Lukić A; Lukić IK; Ivcević S; Nemet D; Seiwerth RS; Ostojić SK; Croucher PI; Marusić A
    Leuk Res; 2010 Jun; 34(6):742-51. PubMed ID: 19926132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.
    Dezorella N; Pevsner-Fischer M; Deutsch V; Kay S; Baron S; Stern R; Tavor S; Nagler A; Naparstek E; Zipori D; Katz BZ
    Exp Cell Res; 2009 Jul; 315(11):1904-13. PubMed ID: 19328780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma.
    Stokes A; Joutsa J; Ala-Aho R; Pitchers M; Pennington CJ; Martin C; Premachandra DJ; Okada Y; Peltonen J; Grénman R; James HA; Edwards DR; Kähäri VM
    Clin Cancer Res; 2010 Apr; 16(7):2022-35. PubMed ID: 20305301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
    Milner JM; Rowan AD; Cawston TE; Young DA
    Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The generation and regulation of functional diversity of malignant plasma cells.
    Nadav L; Katz BZ; Baron S; Cohen N; Naparstek E; Geiger B
    Cancer Res; 2006 Sep; 66(17):8608-16. PubMed ID: 16951174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
    Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
    Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCL-X expression in multiple myeloma: possible indicator of chemoresistance.
    Tu Y; Renner S; Xu F; Fleishman A; Taylor J; Weisz J; Vescio R; Rettig M; Berenson J; Krajewski S; Reed JC; Lichtenstein A
    Cancer Res; 1998 Jan; 58(2):256-62. PubMed ID: 9443402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights from the gene expression profiling of multiple myeloma.
    Claudio JO; Masih-Khan E; Stewart AK
    Curr Hematol Rep; 2004 Jan; 3(1):67-73. PubMed ID: 14695854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin alpha4beta1 involvement in stromal cell-derived factor-1alpha-promoted myeloma cell transendothelial migration and adhesion: role of cAMP and the actin cytoskeleton in adhesion.
    Parmo-Cabañas M; Bartolomé RA; Wright N; Hidalgo A; Drager AM; Teixidó J
    Exp Cell Res; 2004 Apr; 294(2):571-80. PubMed ID: 15023543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient adenovirus-mediated gene expression in malignant human plasma cells: relative lymphoid cell resistance.
    Prince HM; Dessureault S; Gallinger S; Krajden M; Sutherland DR; Addison C; Zhang Y; Graham FL; Stewart AK
    Exp Hematol; 1998 Jan; 26(1):27-36. PubMed ID: 9430511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of receptor activator of nuclear factor kappaB ligand on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma.
    Heider U; Langelotz C; Jakob C; Zavrski I; Fleissner C; Eucker J; Possinger K; Hofbauer LC; Sezer O
    Clin Cancer Res; 2003 Apr; 9(4):1436-40. PubMed ID: 12684416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro maintenance and retroviral transduction of human myeloma cells in long-term marrow cultures.
    Stewart AK; Prince HM; Cappe D; Chu P; Lutzko C; Sutherland DR; Dubé ID
    Cancer Gene Ther; 1997; 4(3):148-56. PubMed ID: 9171933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma cell growth fraction using Ki-67 antigen expression identifies a subgroup of multiple myeloma patients displaying short survival within the ISS stage I.
    Gastinne T; Leleu X; Duhamel A; Moreau AS; Franck G; Andrieux J; Lai JL; Coiteux V; Yakoub-Agha I; Bauters F; Harousseau JL; Zandecki M; Facon T;
    Eur J Haematol; 2007 Oct; 79(4):297-304. PubMed ID: 17692103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of metalloproteinase-7 (matrilysin) by human myeloma cells and its potential involvement in metalloproteinase-2 activation.
    Barillé S; Bataille R; Rapp MJ; Harousseau JL; Amiot M
    J Immunol; 1999 Nov; 163(10):5723-8. PubMed ID: 10553104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase activity in plasma cell dyscrasias.
    Xu D; Zheng C; Bergenbrant S; Holm G; Björkholm M; Yi Q; Gruber A
    Br J Cancer; 2001 Mar; 84(5):621-5. PubMed ID: 11237381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.